Novo Nordisk has introduced Wegovy , a once-weekly weight loss injection, in India. The drug aims to manage obesity and reduce heart risks amid the country’s growing obesity crisis. Novo Nordisk's experimental drug, CagriSema, shows promise beyond weight loss, potentially offering significant cardiovascular benefits. This next-ge Wegovy solution for injection is a prescription medication used alongside a reduced-calorie diet and increased physical activity for long-term weight management. It is indicated for adults and adolescents (12+) with obesity, and for adults with overweight who have at least one weight-related health condition. For adults with known cardiovascular disease and either obesity or overweight, it also helps reduce the risk of major cardiovascular events (cardiovascular death, non-fatal heart attack ... Discover how Wegovy ® (semaglutide) aids in adults with obesity or some with overweight. See Prescribing Info & Medication Guide.
